Abingworth
Chicago, Illinois
Abingworth is an international investment group dedicated to collaborating with life sciences entrepreneurs to develop their ideas into products that have a dramatic impact on health. With over $1 billion under management, Abingworth invests at all stages of development, from start-ups to publicly traded companies, and across all life sciencessectors. Supporting its portfolio companies with a team of 27 at offices in London, Menlo Park, and Boston, Abingworth has invested in 142 life science companies, completed 60 IPOs and 40 mergers and acquisitions.
Founded:1973
Firm Location:Chicago, Illinois • San Francisco, California • Boston, Massachusetts • Menlo Park, California • London
Investor Firms That Co-Invest with Abingworth
SR OneMorgenthaler VenturesHealthCapSV Health InvestorsARCH Venture PartnersThird Rock VenturesRiverVestLightspeed Venture PartnersNew Enterprise Associates (NEA)Westlake Village BioPartnersNexus Venture PartnersVenrockBain Capital Life SciencesATP (Apple Tree Partners)Longwood FundCatalio CapitalvenBioSanofi VenturesMRL Ventures FundSofinnova Investments4BIO CapitalAdvanced Technology VenturesSoffinova PartnersRed Tree Venture CapitalVersant VenturesMPM CapitalPolaris PartnersCanaan Partners5am VenturesOrbiMedEQT Life SciencesGV (Google Ventures)
Abingworth Team
Investors in Boston (MA)
Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Pharmaceuticals (Seed), Investors in Health IT (Series B), Investors in Health & Hospital Services (Series B), Investors in Digital Health (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Seed), Investors in BioTech (Series B), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series B), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Midwest (Other Lists), Investors in Digital Health (Series A), Investors in Health IT (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Boston / New England (Other Lists), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Investors in United Kingdom, Investors in London
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in Health & Hospital Services (Seed), Investors in London (Other Lists), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed)
Investors in Menlo Park (CA)
Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series B), Investors in Health IT (Seed), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Series A), Investors in Health IT (Seed), Investors in San Francisco Bay Area (Other Lists)
Investors in Menlo Park (CA)
Investors in BioTech (Series B), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series A), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in San Francisco Bay Area (Other Lists)
Investors in Boston (MA)
Investors in Pharmaceuticals (Series B), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed)
Investors in Boston (MA)
Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A)
Investors in San Francisco (CA)
Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in San Francisco Bay Area (Other Lists)
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists)
Investors in London
Investors in Diagnostics (Series A), Investors in Diagnostics (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in Diagnostics (Series B), Investors in Health & Hospital Services (Series B), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Diagnostics (Series A), Investors in Health IT (Series A), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series B), Investors in London (Other Lists), Investors in Health & Hospital Services (Series B), Investors in Health IT (Series B), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A)
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in London (Other Lists), Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed)
Investors in Boston (MA)
Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in BioTech (Series B), Investors in Boston / New England (Other Lists)
Investors in London
Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Pharmaceuticals (Series A), Investors in London (Other Lists), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in Health IT (Series A)
Investors in SF Bay Area (CA)
Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Series B), Investors in Diagnostics (Series B), Investors in Diagnostics (Series A), Investors in Medical Devices (Series A), Investors in Diagnostics (Seed), Investors in Medical Devices (Seed), Investors in Medical Devices (Series B), Investors in Digital Health (Series B), Investors in BioTech (Series B), Investors in Digital Health (Series A), Investors in Medical Devices (Series A), Investors in Digital Health (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in BioTech (Series A), Investors in BioTech (Series B), Investors in Digital Health (Series B), Investors in Digital Health (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Digital Health (Series A), Investors in San Francisco Bay Area (Other Lists)
Investors in London
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in London (Other Lists), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)